Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 945 of 6351
-
New wireless device boosts stroke recovery by zapping nerves during rehab
Disease control By invitation onlyTexas Biomedical Device Center (TxBDC) has developed an innovative strategy to enhance recovery of motor and sensory function after neurological injury termed targeted plasticity therapy (TPT). This technique uses brief pulses of vagus nerve stimulation to engage pro-plasticity n…
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Dual-Targeting antibody enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis is a multi-center, open-label, Phase I/II clinical study of MCLA-129 as monotherapy in patients with advanced solid tumors to evaluate the safety, pharmacokinetic characteristics and antitumor activity of MCLA-129.
Phase 1/2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Spinal cord stimulation may help restore movement after paralysis
Disease control CompletedA study to compare electrophysiologic activity of epidural stimulation and dorsal root ganglion stimulation, as well as quantify changes in motor performance with both types of stimulation over the course of 10 rehabilitation sessions.
Sponsor: Peter J. Grahn, Ph.D. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a quick MRI catch more breast cancers in black women?
Diagnosis Ongoing500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT examination 11 months prior to recruitment 3. Heterogeneously and Extremely breas…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Can a rheumatoid arthritis drug tame Immunotherapy's side effects?
Disease control OngoingThis phase II trial investigates the side effects of tocilizumab, ipilimumab, and nivolumab in treating patients with melanoma, non-small cell lung cancer, or urothelial carcinoma that has spread to nearby tissue or lymph nodes (locally advanced). Immunotherapy with monoclonal an…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a lower chemo dose make transplants safer for older patients?
Disease control Recruiting nowBackground: Certain blood cancers can be treated with blood or bone marrow transplants. Sometimes the donor cells attack the recipient's body, called graft-versus-host disease (GVHD). The chemotherapy drug cyclophosphamide helps reduce the risk and severity of GVHD. Researchers …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New antibody drug shows promise for rare bone cancer
Disease control OngoingRandomized, blinded, placebo-controlled, Phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma patients.
Phase 2 • Sponsor: Inhibrx Biosciences, Inc • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New pill could outshine chemo for common blood cancer
Disease control OngoingThe purpose of this study is to compare the efficacy and safety of pirtobrutinib (LOXO-305; Arm A) compared to BR (Arm B) in patients with CLL/SLL who have not been treated. Participation could last up to five years.
Phase 3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New eczema cream shows promise in large trial
Disease control CompletedThis is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.
Phase 3 • Sponsor: Organon and Co • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC
-
Cleaner classroom air may strengthen children's hearts and lungs
Prevention OngoingThis study aims to explore changes in cardiopulmonary function and other health indicators in primary school students with the intervention of air purifiers on a randomized controlled trial.
Sponsor: Fudan University • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Simple drug during surgery may stop chronic pain after breast cancer
Prevention Recruiting nowPhase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.
Phase 3 • Sponsor: University Health Network, Toronto • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
TB vaccine booster shows promise in speeding up recovery
Disease control CompletedProspective, randomized, double-blind, multicentre, placebo-controlled clinical phase IIb trial to evaluate efficacy of RUTI® vaccine in DS- (Drug-Sensitive) and MDR-TB (Multidrug-resistant) patients favourably responding to standard MDR-TB treatment. Time point of vaccination st…
Phase 2 • Sponsor: Archivel Farma S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a drug combo replace stem cell transplants for some myeloma patients?
Disease control Recruiting nowThis is a phase II interventional study evaluating the use of minimal residual disease by next generation sequencing to defer autologous hematopoietic stem cell transplantation (AHCT) in patients with newly diagnosed multiple myeloma (cohort A) and amyloidosis (cohort B).
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can ozonated oil soothe eczema in kids?
Disease control CompletedThis clinical trial is designed to evaluate the efficacy, safety, and tolerability of a topical ozonated vegetable oil formulation in paediatric patients with mild-to-moderate atopic dermatitis. The study follows a randomised, double-blind, placebo-controlled design and compares …
Sponsor: Laboratorios Ozoaqua • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a scanner instantly tell if a lung biopsy is good enough?
Diagnosis CompletedThe aim of the study is to assess the performance of Aquyre Biopsy Scanner technology (the FDA class I medical device) at determining if tissue from the lymph nodes and lung nodules, taken during a bronchoscopy procedure, is adequate for a diagnosis. The study will assess how wel…
Sponsor: Aquyre Bioscience, Inc • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
New rapid test could slash TB diagnosis time in High-Burden regions
Diagnosis CompletedThe performance of a new triage test for active tuberculosis (TB), SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition …
Sponsor: Norwegian Institute of Public Health • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Hope for kidney patients: new pill may slow disease without diabetes
Disease control CompletedResearchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works …
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can mindfulness calm pregnancy anxiety?
Symptom relief CompletedThis randomized controlled intervention study evaluated an 8-week group mindfulness intervention for pregnant women at 20 to 30 gestational weeks. Participants were randomized to mindfulness-based group intervention, group discussion, or health education. The study assessed anxie…
Sponsor: Shenzhen Kangning Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New combo shows promise for rare thymic cancer
Disease control CompletedThis is a multicentric, open-label, single arm phase II study to evaluate the efficacy and safety of the combination of pembrolizumab and lenvatinib in pre-treated thymic carcinoma patients who have progressed after at least one line of platinum-based chemotherapy for advanced di…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could donor immune cells beat COVID-19? new trial begins.
Disease control Recruiting nowThe 2019 Severe Acute Respiratory Syndrome (SARS) is a global pandemic secondary to a novel coronavirus - SARS-CoV-2. The reported case-fatality ratio for SARS-CoV-2 in the United States is 1.8% with a current death toll of \>300,000 and climbing.4 There is no accepted standard o…
Phase 1/2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC